- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04319419
Milk Proteins and Micronutrient Supplementation in Obese Children
Effectiveness of a Supplement Containning Milk Proteins, Vitamins and Minerals to Reduce Fat Deposition, Systemic Inflammation and Improve Nutritional Status in Obese School-age Children
Milk proteins and micronutrients could be beneficial in the prevention and treatment of obesity.
The objective was to evaluate a supplement with milk proteins and multivitamins and minerals with nutrition education on anthropometry, body composition, micronutrient status, blood pressure, lipid profile, systemic inflammation, leptin and insulin resistance in obese children at baseline and after 6 months.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obese children were selected in elementary schools from 5 rural communities of the State of Querétaro. One hundred fifty two obese children (Z-score >2 standard deviations) aged 6-11y were randomly assigned to receive one of two treatments: 1) 237mL/day of milk proteins and multiple micronutrients supplement (MPMS) plus Nutrition Education (NE) program or 2) NE alone for 24 weeks.
Children in both groups were evaluated at baseline and 6 months after treatment initiated. At both times the following variables were evaluated:
Visit 1 (Screening): Mothers and parents received oral and written information regarding all aspects of the study. Informed consent, medical history, demographic information, weight and height were obtained.
Visit 2 (Clinical Laboratory testing): A blood preasure and sample was taken by an specialist. Blood test included Glucose, total cholesterol, triglycerides, HDL cholesterol and LDL cholesterol, Tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10), C reactive protein, insulin and leptin.
Visit 3 (Nutrition Clinic at UAQ): body composition was determined by DEXA. The NE were given at Nutrition Clinic and school to the children's parents each week.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children with obesity (BMI>30)
- Aged: 6 to 11 years
- Both sex
- Parents accepted to participate and signed informant consent
Exclusion Criteria:
- Children with dyslipidemia
- Metabolic disease
- Hypertension
- Physical disability
- Using vitamins and minerals supplements and/or receiving treatment for obesity during the last 3 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Supplement with micronutrients
Nutrition education with a supplement
|
Obese children were divided in 2 groups.
A group received the supplement plus nutrition education and other group was a control, only received nutrition education.
|
Experimental: Nutrition education
Group received only nutrition education
|
Group received nutrition education program during 6 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total body fat
Time Frame: baseline to 6 months
|
change in fat
|
baseline to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total cholesterol
Time Frame: Beaseline to 6 months
|
Change in total cholesterol
|
Beaseline to 6 months
|
HDL
Time Frame: Baseline to 6 months
|
change in HDL
|
Baseline to 6 months
|
LDL
Time Frame: baseline to 6 months
|
change in LDL
|
baseline to 6 months
|
Triglycerides
Time Frame: baseline to 6 months
|
change in triglycerides
|
baseline to 6 months
|
Glucose
Time Frame: baseline to 6 months
|
change in glucose
|
baseline to 6 months
|
Interleukin 6 (IL-6)
Time Frame: baseline to 6 months
|
Change in IL-6
|
baseline to 6 months
|
Interleukin 10 (IL-10)
Time Frame: baseline to 6 months
|
change of IL-10 change in IL-10
|
baseline to 6 months
|
C reactive protein (CRP)
Time Frame: baseline to 6 months
|
change of CRP
|
baseline to 6 months
|
Bone mineral density (BMD)
Time Frame: baseline to 6 months
|
change in BMD
|
baseline to 6 months
|
Body mass index (BMI)
Time Frame: Baseline to 6 months
|
Change in BMI
|
Baseline to 6 months
|
Zinc levels
Time Frame: baseline to 6 months
|
Change in zinc levels
|
baseline to 6 months
|
Iron levels
Time Frame: baseline to 6 months
|
Change in iron levels
|
baseline to 6 months
|
A vitamin levels
Time Frame: baseline to 6 months
|
change in A vitamin levels
|
baseline to 6 months
|
C vitamin levels
Time Frame: baseline to 6 months
|
change of C vitamin levels
|
baseline to 6 months
|
D vitamin levels
Time Frame: baseline to 6 months
|
change in D vitamin levels
|
baseline to 6 months
|
E vitamin levels
Time Frame: baseline to 6 months
|
change of E vitamin levels
|
baseline to 6 months
|
Systolic blood pressure (SBP)
Time Frame: baseline to 6 months
|
change in SBP
|
baseline to 6 months
|
Diastolic blood pressure (DBP)
Time Frame: baseline to 6 months
|
change in (DBP)
|
baseline to 6 months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FNN201104
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Childhood
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Vanderbilt University Medical CenterActive, not recruitingPediatric Obesity | Childhood Obesity | Childhood Onset ObesityUnited States
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
-
University of Alabama at BirminghamCompletedObesity, Childhood | Overweight, ChildhoodUnited States
Clinical Trials on Supplement with micronutrients
-
NATURAmedicatrix SàrlUnknown
-
Université de SherbrookeNestlé Health Science SpainNot yet recruiting
-
McMaster UniversityRecruitingHealthy | Muscle Disuse AtrophyCanada
-
GlaxoSmithKlineCompleted
-
Medecins Sans Frontieres, SpainCompletedChild Malnutrition | Infant MorbidityUganda
-
Université de SherbrookeSociété des Produits Nestlé (SPN)Completed
-
Abbott NutritionChangi General Hospital; SingHealth PolyclinicsCompletedMalnutritionSingapore
-
McMaster UniversityCompletedOverweight and Obesity | Men | WomenCanada
-
Swiss Federal Institute of TechnologyMahidol UniversityNot yet recruitingIron Overload | ThalassemiaThailand
-
Lithuanian University of Health SciencesNot yet recruitingFrail Elderly Syndrome | Malnutrition; Protein